Narveson: NACDS' Effectiveness, Member Engagement Make Chairmanship Amazing Ride

Published Online: Sunday, April 27, 2014
Follow Pharmacy_Times:
PRESS RELEASE

Apirl 27, 2014, Scottsdale, Ariz. – At the National Association of Chain Drug Stores (NACDS) Annual Meeting Business Program today, Bob Narveson drove home the central theme of his chairmanship of the Association: pharmacy’s commitment to serving patients and consumers, and NACDS’ value to chain and associate members as they focus on that priority.

“I wanted to focus on pharmacy services and the importance of medication adherence and patient care. I wanted to represent everyone whether you’re a regional or national chain, or one of our associate members who partner with us,” said Narveson, president and CEO of Thrifty White Pharmacy.

“I can’t imagine a more exhilarating job than working with all of you to ensure NACDS delivers results with the important work of serving patients and consumers as the face of neighborhood healthcare.”

Narveson summarized his one-year term as NACDS chairman of the Board by saying “Wow! What a Ride!” He reported on NACDS’ accomplishments over the past 12 months in every facet of its operations, and reported on the cutting-edge patient care research made possible by the NACDS Foundation.

He credited the Board of Directors and diverse members of NACDS, and the collaboration of the entire NACDS staff, for the Association’s successes.

“Certainly, my team at Thrifty White has always understood the importance of engaging in NACDS, but this year has shown me just how important that engagement is and it’s shown me just how seriously you take it,” Narveson said. “Just know this: everything I’m going to talk about today doesn’t happen without you, it happens because of you.”

Narveson highlighted the successful launch of the NACDS Total Store Expo trade show and strategic exchange, saying: “Together, we all made the show a reality.”

In addition, he cited additional NACDS successes, including the overall member engagement in NACDS; advancement of front-end issues and dialogue through the NACDS Retail Advisory Board; the growth of NACDS RxIMPACT grassroots advocacy and the NACDS Political Action Committee; key state-level Medicaid pharmacy reimbursement victories earned in collaboration with members and state partners; success in shaping the new prescription drug supply chain law; the introduction and advocacy for pharmacy provider status legislation; growing recognition of pharmacy’s importance in public health emergencies; education and training programs related to Drug Enforcement Administration enforcement initiatives; and the launch of the NACDS “Victory Vision” opinion research and communications program.

Narveson summarized the “state of the industry” this way: “As long as we have NACDS, and supplier partners, and chain members like you, we will flourish. That passion has to live on and grow from year to year.

“We are the face of neighborhood healthcare, and as long as we focus on what’s best for our patients and the entire industry the state of our industry is great.”

Narveson acknowledged Jack Bailey, senior vice president, policy, payers, and vaccines, GlaxoSmithKline, who supported and spoke at this morning’s NACDS Annual Meeting Business Program. Similarly, Caitlin Pappas, vice president, U.S. consumer sales, Johnson & Johnson Family of Consumer Companies, is supporting and will speak at Tuesday morning’s NACDS Annual Meeting Business Program.

Today’s Business Program also featured remarks by NACDS President and CEO Steven C. Anderson, IOM, CAE, and a keynote address by Peter H. Diamandis, chairman and CEO, X PRIZE Foundation.
Related Articles
The National Association of Chain Drug Stores lends its support to S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
Avella Specialty Pharmacy announced today that it has been selected by GlaxoSmithKline as one of a select group of pharmacies authorized to continue to distribute Benlysta, a medication approved by the FDA for the treatment of systemic lupus erythematosus in patients who have previously received other therapies.
The value of collaboration through the National Association of Chain Drug Stores was on display today, as the NACDS Regional Chain Conference explored business-to-business partnerships and a public policy agenda that benefits patients and consumers.
A proposal in the Budget of the U.S. Government, Fiscal Year 2016 to increase prescription drug co-payments for TRICARE beneficiaries met with concern by the National Association of Chain Drug Stores.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$